 |
市场调查报告书
商品编码
1685163
儿茶素市场机会、成长动力、产业趋势分析与 2025 - 2034 年预测Catechin Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
||||||
2024 年全球儿茶素市场价值为 183 亿美元，预计 2025 年至 2034 年期间将以 4.5% 的健康复合年增长率成长。这一扩张主要是由于消费者对天然抗氧化剂和有益于整体健康的化合物的偏好日益增长。儿茶素主要来自绿茶，因其在心血管健康、新陈代谢支持和消炎等方面的益处而广受欢迎。随着越来越多的消费者寻求预防性保健解决方案以及对功能性食品、膳食补充剂和护肤产品的需求不断增长，儿茶素在健康和保健领域的地位得到巩固。此外，其在製药、食品饮料和个人护理等行业的日益广泛的应用预计将在未来几年进一步刺激需求。
随着越来越多的人开始追求更健康的生活方式并意识到抗氧化剂的价值，儿茶素市场将大幅成长。人们明显转向以植物为基础的成分和天然的、有科学依据的健康解决方案，这进一步支持了儿茶素在消费品中的作用不断扩大。从膳食补充剂到护肤品，儿茶素被广泛采用，是因为它们能够解决肥胖、糖尿病和压力相关疾病等现代健康问题。儿茶素除了对心血管和代谢有益外，现在还被视为任何想要增强免疫系统和抗发炎的人的必需成分。
| 市场范围 | |
|---|---|
| 起始年份 | 2024 |
| 预测年份 | 2025-2034 |
| 起始值 | 183亿美元 |
| 预测值 | 281亿美元 |
| 复合年增长率 | 4.5％ |
根据类型，儿茶素市场分为表儿茶素、表儿茶素没食子酸酯 (ECG)、表没食子儿茶素 (EGC)、表没食子儿茶素没食子酸酯 (EGCG) 等。表儿茶素凭藉其独特的健康益处和多样化的应用，在 2024 年占据市场主导地位，创造 70 亿美元的收入。
儿茶素的来源主要有绿茶、可可、葡萄和其他植物成分。绿茶占据最大的市场份额，到 2024 年将占据 52.1% 的收入。这种主导地位归因于绿茶的高抗氧化剂含量以及促进心臟健康、增强新陈代谢和帮助控制体重的良好声誉。
在美国，儿茶素市场在 2024 年的产值达到 52 亿美元。这一增长得益于消费者对健康和保健意识的不断增强，以及对天然功能性成分的需求激增。肥胖、心血管疾病和糖尿病等健康问题正在推动食品、饮料和营养保健品领域富含儿茶素的产品的增加。随着营养保健食品产业的扩张，向预防性医疗保健的转变为儿茶素在旨在改善整体健康的产品中的应用创造了更多机会。
目录
第 1 章：方法论与范围
- 市场范围和定义
- 基础估算与计算
- 预测计算
- 资料来源
- 基本的
- 次要
- 付费来源
- 公共资源
第 2 章：执行摘要
第 3 章：产业洞察
- 产业生态系统分析
- 影响价值链的因素
- 利润率分析
- 中断
- 未来展望
- 製造商
- 经销商
- 供应商概况
- 利润率分析
- 重要新闻及倡议
- 监管格局
- 衝击力
- 成长动力
- 注重健康的消费者
- 对天然成分的需求不断增长
- 扩充应用
- 产业陷阱与挑战
- 生产成本高
- 原料供应有限
- 成长动力
- 成长潜力分析
- 波特的分析
- PESTEL 分析
第四章：竞争格局
- 介绍
- 公司市占率分析
- 竞争定位矩阵
- 战略展望矩阵
第 5 章：市场估计与预测：按类型，2021 年至 2034 年
- 主要趋势
- 表儿茶素
- 表儿茶素没食子酸酯 (ECG)
- 表没食子儿茶素 (EGC)
- 表没食子儿茶素没食子酸酯 (EGCG)
- 其他的
第六章：市场估计与预测：依来源，2021-2034 年
- 主要趋势
- 绿茶儿茶素
- 可可儿茶素
- 葡萄儿茶素
- 其他的
第 7 章：市场估计与预测：按功能，2021 年至 2034 年
- 主要趋势
- 抗氧化剂
- 心血管健康
- 体重管理
- 皮肤健康
- 消炎剂
- 大脑健康
- 其他的
第 8 章：市场估计与预测：按应用，2021 年至 2034 年
- 主要趋势
- 功能性食品
- 功能性饮料
- 化妆品和护肤品
- 营养保健品
- 其他的
第 9 章：市场估计与预测：按地区，2021 年至 2034 年
- 主要趋势
- 北美洲
- 我们
- 加拿大
- 欧洲
- 英国
- 德国
- 法国
- 义大利
- 西班牙
- 俄罗斯
- 亚太地区
- 中国
- 印度
- 日本
- 韩国
- 澳洲
- 拉丁美洲
- 巴西
- 墨西哥
- 中东及非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
第十章：公司简介
- INDOFINE Chemical Company
- Botaniex
- Vital-Chem
- Caymanchem
- Biosynth
- Taiyo
- Hangzhou Qinyuan natural plant technology
- Novanat Bioresources
- Tata Chemicals Limited
- Indena
The Global Catechin Market, valued at USD 18.3 billion in 2024, is projected to grow at a healthy CAGR of 4.5% from 2025 to 2034. This expansion is largely driven by a growing consumer preference for natural antioxidants and compounds that promote overall health. Catechins, primarily sourced from green tea, are gaining widespread popularity for their proven benefits in areas such as cardiovascular health, metabolism support, and inflammation reduction. With more consumers seeking preventive healthcare solutions and the growing demand for functional foods, dietary supplements, and skincare products, catechins have solidified their place in the health and wellness sector. Additionally, their increasing use across industries like pharmaceuticals, food and beverages, and personal care is expected to further boost demand over the coming years.
As more people turn to healthier lifestyles and become aware of the value of antioxidants, the catechin market is set for substantial growth. There is a noticeable shift toward plant-based ingredients and natural, science-backed health solutions, which further supports catechins' expanding role in consumer products. The adoption of catechins in various forms, from dietary supplements to skincare, is driven by their ability to address modern health concerns such as obesity, diabetes, and stress-related conditions. Alongside their cardiovascular and metabolic benefits, catechins are now seen as an essential ingredient for anyone looking to boost their immune system and fight inflammation.
| Market Scope | |
|---|---|
| Start Year | 2024 |
| Forecast Year | 2025-2034 |
| Start Value | $18.3 Billion |
| Forecast Value | $28.1 Billion |
| CAGR | 4.5% |
By type, the catechin market is segmented into epicatechin, epicatechin gallate (ECG), epigallocatechin (EGC), epigallocatechin gallate (EGCG), and others. Epicatechin led the market in 2024, generating USD 7 billion in revenue thanks to its unique health benefits and diverse applications.
The sources of catechins are primarily green tea, cocoa, grapes, and other plant-based ingredients. Green tea holds the largest market share, capturing 52.1% of the revenue in 2024. This dominance is attributed to green tea's high antioxidant content and established reputation for promoting heart health, enhancing metabolism, and assisting in weight management.
In the U.S., the catechin market generated USD 5.2 billion in 2024. This growth is fueled by increasing consumer awareness of health and wellness, along with a surge in demand for natural, functional ingredients. Health concerns like obesity, cardiovascular diseases, and diabetes are driving the rise in catechin-enriched products across the food, beverage, and nutraceutical sectors. As the nutraceuticals industry expands, the shift toward preventive healthcare has created more opportunities for catechins in products aimed at improving overall well-being.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definitions
- 1.2 Base estimates & calculations
- 1.3 Forecast calculations
- 1.4 Data sources
- 1.4.1 Primary
- 1.4.2 Secondary
- 1.4.2.1 Paid sources
- 1.4.2.2 Public sources
Chapter 2 Executive Summary
- 2.1 Industry synopsis, 2021-2034
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.1.1 Factor affecting the value chain
- 3.1.2 Profit margin analysis
- 3.1.3 Disruptions
- 3.1.4 Future outlook
- 3.1.5 Manufacturers
- 3.1.6 Distributors
- 3.2 Supplier landscape
- 3.3 Profit margin analysis
- 3.4 Key news & initiatives
- 3.5 Regulatory landscape
- 3.6 Impact forces
- 3.6.1 Growth drivers
- 3.6.1.1 Health-conscious consumers
- 3.6.1.2 Rising demand for natural ingredients
- 3.6.1.3 Expanding applications
- 3.6.2 Industry pitfalls & challenges
- 3.6.2.1 High production costs
- 3.6.2.2 Limited availability of raw materials
- 3.6.1 Growth drivers
- 3.7 Growth potential analysis
- 3.8 Porter’s analysis
- 3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Competitive positioning matrix
- 4.4 Strategic outlook matrix
Chapter 5 Market Estimates & Forecast, By Type, 2021-2034 (USD Billion) (Kilo Tons)
- 5.1 Key trends
- 5.2 Epicatechin
- 5.3 Epicatechin gallate (ECG)
- 5.4 Epigallocatechin (EGC)
- 5.5 Epigallocatechin gallate (EGCG)
- 5.6 Others
Chapter 6 Market Estimates & Forecast, By Source, 2021-2034 (USD Billion) (Kilo Tons)
- 6.1 Key trends
- 6.2 Green tea catechins
- 6.3 Cocoa catechins
- 6.4 Grape catechins
- 6.5 Others
Chapter 7 Market Estimates & Forecast, By Function, 2021-2034 (USD Billion) (Kilo Tons)
- 7.1 Key trends
- 7.2 Antioxidants
- 7.3 Cardiovascular health
- 7.4 Weight management
- 7.5 Skin health
- 7.6 Anti-inflammatory
- 7.7 Brain health
- 7.8 Others
Chapter 8 Market Estimates & Forecast, By Application, 2021-2034 (USD Billion) (Kilo Tons)
- 8.1 Key trends
- 8.2 Functional foods
- 8.3 Functional beverages
- 8.4 Cosmetics and skincare
- 8.5 Nutraceuticals
- 8.6 Others
Chapter 9 Market Estimates & Forecast, By Region, 2021-2034 (USD Billion) (Kilo Tons)
- 9.1 Key trends
- 9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
- 9.3 Europe
- 9.3.1 UK
- 9.3.2 Germany
- 9.3.3 France
- 9.3.4 Italy
- 9.3.5 Spain
- 9.3.6 Russia
- 9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 India
- 9.4.3 Japan
- 9.4.4 South Korea
- 9.4.5 Australia
- 9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.6 MEA
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
Chapter 10 Company Profiles
- 10.1 INDOFINE Chemical Company
- 10.2 Botaniex
- 10.3 Vital-Chem
- 10.4 Caymanchem
- 10.5 Biosynth
- 10.6 Taiyo
- 10.7 Hangzhou Qinyuan natural plant technology
- 10.8 Novanat Bioresources
- 10.9 Tata Chemicals Limited
- 10.10 Indena
